Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0037 | 0.1372 | 0.3708 |
Mycobacterium leprae | PROBABLE THIOESTERASE TESA | 0.0043 | 0.179 | 0.4398 |
Mycobacterium tuberculosis | Probable membrane bound polyketide synthase Pks6 | 0.0078 | 0.4071 | 1 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0052 | 0.2365 | 0.581 |
Brugia malayi | Beta-ketoacyl synthase, N-terminal domain containing protein | 0.0052 | 0.2365 | 0.0288 |
Mycobacterium tuberculosis | Probable multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0055 | 0.2579 | 0.6337 |
Onchocerca volvulus | Fatty acid synthase homolog | 0.0094 | 0.5133 | 0.5103 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSC | 0.0055 | 0.2579 | 0.6337 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks5 | 0.005 | 0.226 | 0.5551 |
Onchocerca volvulus | 0.009 | 0.4919 | 0.4738 | |
Mycobacterium tuberculosis | Probable polyketide synthase Pks8 | 0.0042 | 0.1737 | 0.4267 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks7 | 0.0055 | 0.2579 | 0.6337 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks1 | 0.0037 | 0.1394 | 0.3424 |
Mycobacterium tuberculosis | Polyketide synthase Pks2 | 0.005 | 0.226 | 0.5551 |
Mycobacterium tuberculosis | Probable thioesterase TesA | 0.0043 | 0.179 | 0.4398 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSE | 0.0034 | 0.1197 | 0.2941 |
Mycobacterium ulcerans | polyketide synthase | 0.0055 | 0.2579 | 0.6337 |
Echinococcus multilocularis | muscleblind protein 1 | 0.0167 | 1 | 0.5 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0052 | 0.2365 | 0.581 |
Loa Loa (eye worm) | hypothetical protein | 0.0087 | 0.471 | 0.443 |
Mycobacterium leprae | Probable multifunctional mycocerosic acid synthase membrane associated enzyme Mas | 0.0055 | 0.2579 | 0.6337 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0055 | 0.2579 | 0.6337 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0055 | 0.2579 | 1 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0052 | 0.2365 | 0.581 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSB | 0.0042 | 0.1691 | 0.4155 |
Loa Loa (eye worm) | fatty acid synthase | 0.0051 | 0.2319 | 0.1913 |
Loa Loa (eye worm) | hypothetical protein | 0.0029 | 0.0849 | 0.0365 |
Onchocerca volvulus | Huntingtin homolog | 0.0137 | 0.8007 | 1 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0052 | 0.2365 | 0.581 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0042 | 0.1691 | 0.4155 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks15 | 0.0021 | 0.0311 | 0.0765 |
Loa Loa (eye worm) | hypothetical protein | 0.0167 | 1 | 1 |
Mycobacterium tuberculosis | Polyketide synthase Pks12 | 0.0055 | 0.2579 | 0.6337 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0052 | 0.2365 | 0.581 |
Loa Loa (eye worm) | hypothetical protein | 0.0167 | 1 | 1 |
Mycobacterium leprae | Probable polyketide synthase Pks1 | 0.0055 | 0.2579 | 0.6337 |
Mycobacterium ulcerans | polyketide synthase Pks9 | 0.0034 | 0.1197 | 0.2941 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSA | 0.0052 | 0.2365 | 0.581 |
Brugia malayi | hypothetical protein | 0.0137 | 0.8007 | 0.7464 |
Echinococcus multilocularis | muscleblind protein | 0.0167 | 1 | 0.5 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks9 | 0.003 | 0.0877 | 0.2155 |
Mycobacterium leprae | Polyketide synthase Pks13 | 0.0078 | 0.4071 | 1 |
Echinococcus granulosus | muscleblind protein | 0.0167 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0137 | 0.8007 | 0.7901 |
Mycobacterium ulcerans | multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0055 | 0.2579 | 0.6337 |
Mycobacterium ulcerans | thioesterase | 0.0043 | 0.179 | 0.4398 |
Mycobacterium ulcerans | polyketide synthase Pks13 | 0.0078 | 0.4071 | 1 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsE | 0.0034 | 0.1197 | 0.2941 |
Onchocerca volvulus | Huntingtin homolog | 0.0137 | 0.8007 | 1 |
Mycobacterium ulcerans | polyketide synthase | 0.0052 | 0.2365 | 0.581 |
Mycobacterium tuberculosis | Phenyloxazoline synthase MbtB (phenyloxazoline synthetase) | 0.0049 | 0.2139 | 0.5254 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsB | 0.0042 | 0.1691 | 0.4155 |
Mycobacterium tuberculosis | Polyketide synthetase MbtC (polyketide synthase) | 0.0018 | 0.0102 | 0.0251 |
Mycobacterium ulcerans | thioesterase TesA | 0.0043 | 0.179 | 0.4398 |
Toxoplasma gondii | beta-ketoacyl synthase, N-terminal domain-containing protein | 0.0034 | 0.1154 | 0.2574 |
Mycobacterium tuberculosis | Polyketide synthase Pks13 | 0.0078 | 0.4071 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0137 | 0.8007 | 0.7901 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0052 | 0.2365 | 0.581 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSD | 0.0052 | 0.2365 | 0.581 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0052 | 0.2365 | 0.581 |
Brugia malayi | oxidoreductase, zinc-binding dehydrogenase family protein | 0.0098 | 0.5453 | 0.4216 |
Loa Loa (eye worm) | AMP-binding enzyme family protein | 0.0049 | 0.2139 | 0.1723 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | = 0.15 ug ml-1 | Antitubercular activity against Mycobacterium tuberculosis BCG | ChEMBL. | 24246731 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.